Shares of Ambev S.A. (BVMF:ABEV3; NYSE:ABEV) advanced approximately 2.5% during Tuesday's trading session on the B3 exchange, reaching near R$16.26. This upward move has pushed the stock above the consensus 12-month price target of R$16.21 set by analysts, leaving limited upside cushion in the event of a typical quarterly performance.
Q2 Earnings Preview and EBITDA Range
Ambev is scheduled to report its second-quarter financial results before the opening bell on July 30, covering both B3 and NYSE listings. The company's earnings webcast will commence at 12:30 BRT. Preliminary forecasts from four major financial institutions—XP Inc. (NASDAQ:XP), Bradesco BBI, Itaú BBA, and JPMorgan Chase & Co. (NYSE:JPM)—indicate a rare consensus on EBITDA figures, with estimates spanning a narrow range of R$6.50 billion to R$6.68 billion. The spread of just 2.8% underscores the tight expectations, meaning any deviation toward the lower bound could disappoint investors.
Detailed Forecasts and Key Metrics
According to XP's projections, Ambev's net revenue is expected at R$21.1 billion, with adjusted EBITDA of R$6.60 billion and net profit of R$2.90 billion. Bradesco BBI aligns with EBITDA at R$6.60 billion but forecasts a slightly higher adjusted net profit of R$3.00 billion. Itaú BBA projects EBITDA at R$6.50 billion, while JPMorgan estimates R$6.68 billion in EBITDA and net profit of R$3.11 billion. The primary divergence lies in Brazil beer volume growth, with XP predicting a 5% year-over-year increase, Itaú BBA expecting 8%, and JPMorgan in the middle at 7%. This places the emphasis on volume-to-margin conversion as a key indicator for earnings quality.
Market Context and Analyst Commentary
XP analysts Leonardo Alencar and Leonardo Paiva highlighted that milder weather and soft demand in Canada and Latin America South have partially offset the benefits from easier comparisons in Brazil Beer. These headwinds could pressure results. In the first quarter, CEO Carlos Lisboa described the period as "a solid start to 2026," with organic revenue up 8.1% and normalized EBITDA climbing 10.1%. The normalized EBITDA margin expanded by 60 basis points to 33.6%. However, Brazil Beer's EBITDA margin contracted by 60 basis points due to a 14.6% increase in cash cost per hectolitre. Ambev has maintained its full-year cash-cost growth guidance of 4.5% to 7.5%.
Outlook and Risks
With the stock trading above the average analyst target, the earnings outcome becomes critical. Strong volume growth alone may not suffice unless accompanied by stable pricing and rigorous cost control. An EBITDA figure near R$6.5 billion would align with certain projections but could disappoint investors who have driven shares higher in anticipation. Risks include cooler temperatures, persistent soft international demand, and a resurgence of cost pressures in Brazil, which could push EBITDA toward the lower end of the range. Conversely, higher pricing or an improved product mix could help mitigate these risks.
